Funding
The Research carried out at Inserm UMR 1096 benefits from the following sources of public funding and sponsors:
General funds:
Targeted funding:
ANR SAPHIR
ERA-CVD: LYMIT-DIS
RHU STOP-AS
EU FP7: FIBRO-TARGETS
European Cooperation in Science and Technology (COST) program BM1301 ADMIRE
FHU REMOD-VHF
Normandy Region : ENTRAC
Fondation Recherche Medicale
Fondation de France
Fondation du Rein
